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Summary
Objectives: Diagnostic and therapeutic practice guidelines have been established for classi-
cal forms of benign otitis externa. However, these guidelines do not include unusual forms of
the disease, especially ‘‘invasive’’ otitis externa. No consensual diagnostic ﬂow diagram has
been published in the literature, which frequently results in delayed diagnosis and inappro-
priate primary care management. The objective of this study was to analyse the primary care
management practices of malignant otitis externa (MOE).
Material and methods: Retrospective study of 22 cases of MOE managed in our tertiary care
centre over a 6-year period (2004—2010).
Results: All but one of the patients presented a systemic or local predisposing factor. The
mean interval between onset of the ﬁrst symptoms and referral to our tertiary care centre was
13weeks (range: 1 to 12months); 77% of patients were referred by a private ENT specialist, 14%
were referred by a an emergency department and 9% were referred by a hospital department.
Seventeen patients (81%) had received one or more courses of inappropriate systemic antibiotics
during this interval (oral in 15 cases, parenteral in two cases, multiple treatments in 13 cases).
The mean duration of each course of antibiotics was 12 days (range: 7 to 21 days). All patients
also received local antibiotic ear drops (aminoglycosides or ﬂuoroquinolones).
Conclusions: The practice audit constantly revealed delayed management of MOE, often result-
ing in inappropriate antibiotic prescriptions. Publication of practice guidelines for primary and
secondary care practitioners therefore appears to be essential.
© 2012 Elsevier Masson SAS. All rights reserved.∗ Corresponding author. Tel.: +04 92 03 17 68.
E-mail address: guevara.n@chu-nice.fr (N. Guevara).
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is externa, corresponds to osteomyelitis of the skull base,
ypically due to Pseudomonas aeruginosa, initially arising in
served.
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he external auditory canal (EAC). Extension to the deep soft
issues of the face and to the central nervous system deter-
ines the severity of this infection. The ﬁrst cases described
y Chandler in 1968 [1] classically concerned elderly dia-
etic men with extremely painful otitis externa associated
ith facial palsy.
Although this clinical presentation is well known and
enerally leads to rapid, appropriate management, diagnos-
ic difﬁculties may be encountered, especially at the early
tages, resulting in inappropriate primary care management
hat delays and complicates subsequent management [2],
s, early in the course of this necrotic infection, the clinical
eatures are identical to those of classical otitis externa. The
resence of systemic predisposing factors, otoscopic signs
nd especially resistance to topical treatment should raise
he suspicion of MOE, even in younger, non-diabetic sub-
ects. An early clinical diagnosis conﬁrmed by imaging and
icrobiology allows initiation of appropriate antibiotic the-
apy that very probably limits the extent of necrosis and the
evelopment of central nervous system complications [3].
We conducted a retrospective study of cases admitted
o our tertiary care centre with particular attention to the
rimary care management of these cases. The objective of
his study was therefore to deﬁne the traps and errors asso-
iated with the diagnosis and primary care management of
OE in order to propose improvement of clinical practice.
aterial and methods
ll consecutive patients managed in the Department of
torhinolaryngology and Head and Neck Surgery of Nice
niversity Hospital with a diagnosis of MOE between
st July 2004 and 31August 2010 were included in this study.
In our unit, the diagnosis of MOE was deﬁned by the pres-
nce of clinical signs of inﬂammation of the EAC conﬁrmed
y radiological signs of bone involvement (computed tomo-
raphy and/or magnetic resonance imaging [MRI] and/or
cintigraphy).
Carcinomas of the EAC were excluded from this study.
The following data were retrospectively collected from
he medical ﬁles of the ENT and infectious diseases depart-
ents for each patient included:
epidemiological data;
◦ analysis of the clinical setting and systemic predis-
posing factors,
◦ climate and local predisposing factors;
initial clinical data:
◦ clinical presentation (at the time of admission),
◦ previous management;
laboratory, microbiological and histopathological analysis
(at the time of admission).
Data were entered into spreadsheet software (Microsoft
fﬁce Excel® 2008—Microsoft Corporation© —Redmond,
SA).esults
wenty-two cases (21 patients) satisfying the inclusion crite-
ia were included in this retrospective study.
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linical setting and systemic predisposing factors
he epidemiological characteristics of these 22 cases are
ummarized in Fig. 1. One patient was managed twice: for a
esion on the right side in 2004 (case 1, Fig. 1) and then for
lesion of the left side in 2010 (case 19, Fig. 1). The mean
ge of the patients of this series was 73± 11 years and 77%
f them were males (sex-ratio of 3.4/1).
Twelve patients (55%) were diabetic, and eight of them
ere considered to be poorly controlled (HbA1c > 8%).
OE was the presenting sign of diabetes in one case
case 21, Fig. 1). Serum protein electrophoresis was per-
ormed in 14 patients, revealing hypogammaglobulinaemia
n four cases (29%), including one patient who was also
iabetic. HIV serology was determined in 10 cases and
as negative in all cases. Overall, at least one systemic
redisposing factor was identiﬁed in 15 out of 22 cases
68%).
limate and local predisposing factors
nset of symptoms was situated between April and Septem-
er in every case. Twenty patients (95% of cases) attended
ur outpatients department between May and December.
Marked exposure to water (spa therapy in ﬁve cases,
wimming or diving in three cases) was also formally iden-
iﬁed in eight cases (38%) (Fig. 1). In two of these eight
ases (corresponding to the same patient), the patient per-
ormed traumatic manoeuvres himself (cleaning of EAC with
knife!).
Two other patients also underwent potentially traumatic
anoeuvres (extraction of a cerumen plug) during the days
receding onset of the infection.
MOE was the ﬁrst sign of Wegener’s granulomatosis
nvolving the EAC and parotid gland in one case. Finally,
ne patient had received external beam radiotherapy and
hemotherapy 25 years previously for cervical lymphoma
precise irradiation ﬁelds not speciﬁed).
Overall, a potential local predisposing factor was there-
ore identiﬁed in 12 cases (55%). Only one of the 22 patients
f this series did not present either a systemic or a local
redisposing factor (case 13, Fig. 1).
revious management
he mean interval between onset of the ﬁrst symptoms
nd referral to our centre was 13.4± 6weeks, i.e. about
months with a range of 1month to 12months and a median
f 10weeks.
Seventy-seven percent of cases were referred by a pri-
ate ENT specialist, 14% were admitted via an emergency
epartment and 9% were referred by a hospital department.
In 17 cases (81%), one or several courses of systemic
ntibiotics had been prescribed during this period (oral in
5 cases, parenteral in two cases, multiple treatments in
3 cases). The various types of antibiotics prescribed are
ndicated in Fig. 2. A ﬂuoroquinolone was prescribed in
ine out of 17 cases, including ciproﬂoxacin active against
. aeruginosa in eight cases, always as monotherapy and at
he standard dosage.
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Figure 1 Epidemiological characteristics of the patients of this series.
prio
CFigure 2 Antibiotic therapy
The mean duration of each course of antibiotics
was 11.6± 3 days (range: 7 to 21 days). These patients
always received concomitant topical treatment with
antibiotic eardrops (aminoglycosides or ﬂuoroqui-
nolones).
F
2
ar to management in our unit.
linical presentationig. 3 summarizes the clinical presentation of these
2 patients. Symptoms were unilateral in every case. Ear-
che was the symptom most frequently reported and was
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tFigure 3 Clinical presentat
resent in 100% of cases. All patients were taking or had
een taking level 1 or 2 analgesics at the time of diagnosis.
torrhoea was present in 16 cases (73%).
Otoscopic examination showed lesions of the EAC in every
ase, with a polyp or granuloma in 77% of cases, ﬂuctuat-
ng abscess of the ﬂoor of the EAC in two cases, and global
nﬂammatory stenosis of the EAC in the remaining two cases.
A cranial nerve lesion was observed at the time of the
rst visit in seven patients (32%): seven cases presented
acial palsy, associated with ipsilateral vagus nerve palsy in
ne case (demonstrated by dysphonia). The median time to
anagement of these patients was identical to that of
atients without cranial nerve lesions.
Parotid swelling was present in two cases (cases 11 and
6, Fig. 3). Signs of temporomandibular joint dysfunction
ere present in three cases. Only four patients were febrile
18%).
maging
he initial diagnostic work-up comprised computed tomo-
raphy (CT) in 22 cases (100%), magnetic resonance imaging
MRI) in 13 cases (59%) and Technetium-99 (99mTc) scintigra-
hy in two cases. CT showed no signs of bone lysis in 23% of
ases (ﬁve out of 22). The diagnosis was established by 99mTc
cintigraphy in two cases (intense bone uptake) and MRI in
hree cases (inﬁltration of retrocondylar fat).
aboratory parameters and microbiologyacteriology specimens were obtained in every case. The
athogen was demonstrated in 20 cases (95%): in our unit
n 15 cases, and before referral to our centre in ﬁve cases
Fig. 4).
H
H
1f the patients of this series.
Cultures were positive for P. aeruginosa in 17 cases (77%).
. aeruginosa was associated with another micro-organism
n three out of 17 cases, considered to be a contami-
ant in two cases (enterobacteria and coagulase-negative
taphylococcus in one case, Candida parapsilosis in one
ase), and a potential pathogen in 1 case (Candida albi-
ans).
The other bacteria isolated were:
Achromobacter xylosoxydans in one case;
Actinomyces meyeri, associated with an animal strain of
Corynebacterium in one case;
Escherichia coli in one case;
A combination of bacteria of the gastrointestinal ﬂora:
E. coli, E. faecalis, K. oxytoca.
Antibiotic susceptibility testing was performed in every
ase. P. aeruginosa was sensitive to ciproﬂoxacin and
eftazidime in 100% of cases. Minimum inhibitory con-
entrations (MIC) for ciproﬂoxacin and ceftazidime were
etermined in each case. One P. aeruginosa strain had a high
IC (0.64mg/L).
Laboratory signs of inﬂammation were investigated in
1 cases and were present in 15 cases (71%): elevation of
-Reactive Protein (CRP) greater than 10mg/L in 13 cases
range: 16 to 101, mean: 51). Erythrocyte sedimentation
ate was determined in 1 case and was elevated (81mm at
he ﬁrst hour).istopathology
istological examination excluded amalignant tumour in the
3 cases with a doubtful diagnosis.
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Discussion
This study revealed a clear-cut conclusion concerning the
primary care management of MOE: severely delayed diag-
nosis, consequently associated with multiple inappropriate
treatments. Evidence-based guidelines are available for
classical forms of benign otitis externa [4], but these guide-
lines exclude particular forms of the disease, especially
invasive forms: in some cases, this benign disease can evolve
towards a necrotizing process arising in the bone of the EAC,
and then spreading to cause osteomyelitis of the skull base,
and involvement of the deep soft tissues of the face, or even
the central nervous system, causing cranial nerve lesions and
life-threatening implications.
Although various authors have proposed diagnostic crite-
ria [3,5—20] (Fig. 5), no consensual diagnostic ﬂow diagram
has been published in the literature. This is particularly
important, as early diagnosis, allowing rapid management,
could be a major prognostic factor [3]. The most charac-
teristic feature of MOE, rather than the classical clinical
signs (granulation tissue of the EAC in a context of symp-
toms of otitis externa in an immunodepressed setting) is
that it is refractory to conventional treatments. In the
present series, seven out of 22 patients did not present
any systemic predisposing factors, but all patients pre-
sented signs of otitis externa for more than 4weeks. All
patients had received several topical treatments, associ-
ated in every case with one or more courses of systemic
antibiotics therapy, often prescribed by several practition-
ers. According to 70.6% of authors [3,5—20] (Fig. 5), the
poor response to conventional treatment (not including
systemic antibiotics) constitutes a mandatory diagnostic cri-
terion.
Current guidelines for benign otitis externa support this
dogma: according to the Good Clinical Practice guide of the
Cochrane Database [4], benign otitis externa should respond
to well conducted topical treatment within 48 or 72 hours
after aspiration of the EAC and the diagnosis should be
reviewed after 2weeks.However, practice audits constantly show delayed
management, and often inappropriate initial management.
Delayed management for up to more than 3months after
onset of the symptoms has also been reported in the
f
i
yresults in our series.
iterature [2]. In the present study, the mean time to diag-
osis was 13weeks.
As a result of this uncertain diagnosis, many empirical
ntibiotics with a spectrum that does not correspond to the
acterial epidemiology of MOE are prescribed (for exam-
le amoxicillin-clavulanic acid and pristinamycin, to which
. aeruginosa is naturally resistant). Moreover, antibiotics
re generally useless in the case of benign otitis externa,
nd inappropriate and prescribed for an insufﬁcient dura-
ion in the case of MOE, which requires prolonged antibiotic
herapy in order to treat osteomyelitis. Multiple courses
f local antibiotics are also used concomitantly, which can
redispose to the development of resistant strains (espe-
ially to ciproﬂoxacin [14,21], but also and more recently
o ceftazidime [22]) and the risk of negative cultures [23].
owever, microbiological documentation is required to cor-
ectly adapt the antibiotic therapy of MOE. Due to the low
requency of ear swabs performed in the primary care set-
ing (only 5/22 patients in this series), identiﬁcation of the
athogen was usually performed in our unit, and cultures
ere repeated 48 hours after stopping all topical and/or sys-
emic local antibiotics, if necessary. No resistant strains of
. aeruginosa were detected in the present series. However,
ne strain of P. aeruginosa with a high MIC was isolated from
ne patient who received ciproﬂoxacin, requiring 6weeks of
wo-agent antibiotic therapy.
In a study conducted in Athens, Eleftheriadou et al. [24]
oncluded that patients referred by rural centres situated
way from the capital had a poorer prognosis than patients
anaged immediately in Athens, although the difference
as not statistically signiﬁcant. They emphasized the role
f primary care physicians in referral of high-risk patients
o specialized centres to ensure more rapid management.
Rubin Grandis et al. [25] described an archetypal exam-
le of delayed diagnosis: a patient received 12 courses of
ntibiotics, often based on effective molecules, and always
or periods of less than two weeks. The patient was referred
o a reference centre only after 18months without improve-
ent.
According to Johnson and Ramphal [9], the growing dif-usion of information to physicians is largely responsible for
mprovement of the prognosis of this disease over recent
ears.
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onclusion
his study illustrates the diagnostic difﬁculties encoun-
ered in the primary care management of patients with
OE, especially at the early stages of the disease,
hich delayed initiation of appropriate treatment. Pub-
ication of practice guidelines appears to be neces-
ary in view of the diagnostic delay ranging from
weeks to 1 year and the inappropriate antibiotic prescrip-
ions:
ﬁrst of all, the physician must consider the possibility of
this diagnosis. Any case of otitis externa refractory to
well conducted topical treatment must raise the suspi-
cion of MOE, even in non-diabetic, non-immunodepressed
and female subjects;
the diagnosis must then be conﬁrmed by cultures (after
stopping antibiotic eardrops for 48 hours, and obviously
after stopping any systemic antibiotics) and appropriate
imaging (computed tomography of the petrous tem-
poral bone completed, when negative, by 99mTc bone
scan or magnetic resonance imaging). Depending on
the clinical presentation, various differential diagnoses,
especially malignant diseases of the EAC, must be
excluded;
ﬁnally, culture-directed antibiotic therapy, at maximum
dosage with good bone diffusion, initially as dual-agent
therapy to decrease the risks of failure and resistance,
must be conducted in collaboration with an infectious
diseases physician.In this way, the time to initiation of appropri-
te antibiotic therapy could be reduced to 2weeks,
hich could possibly decrease the risk of cranial nerve
esions.
[
[nd optional) in the literature [3,5—20].
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